Primary Breast Neuroendocrine Tumor.

Journal Article (Journal Article)

Breast primary neuroendocrine tumors (BNETs) are rare, making up less than 1% of all breast carcinoma diagnosis. Their detection relies on physical exams and mammography. Diagnosis of primary BNET requires findings of no other source of neuroendocrine tumor (eg, pancreatic, lung, and appendix). Histopathologically, they typically stain positive for chromogranin A and/or synaptophysin, as do most neuroendocrine tumors. Currently, there are no agreed upon and standardized treatment protocols as it is a rare diagnosis. Treatment protocols are often built on anecdotal evidence and small case reports and series. Here we discuss a case of BNET in a 51-year-old female and discuss commonly encountered treatment protocols.

Full Text

Duke Authors

Cited Authors

  • Jones, VM; Cairns, A; Chiba, A; Howard-McNatt, M

Published Date

  • August 2022

Published In

Volume / Issue

  • 88 / 8

Start / End Page

  • 1898 - 1900

PubMed ID

  • 35333626

Electronic International Standard Serial Number (EISSN)

  • 1555-9823

Digital Object Identifier (DOI)

  • 10.1177/00031348221086781


  • eng

Conference Location

  • United States